0001683168-23-008940.txt : 20231218
0001683168-23-008940.hdr.sgml : 20231218
20231218193112
ACCESSION NUMBER: 0001683168-23-008940
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hancock Richard B
CENTRAL INDEX KEY: 0001723288
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 231495242
MAIL ADDRESS:
STREET 1: 14282 FRANKLIN AVE.
CITY: TUSTIN
STATE: CA
ZIP: 92780
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 14191 MYFORD ROAD
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2023-12-14
0
0000704562
Avid Bioservices, Inc.
CDMO
0001723288
Hancock Richard B
14191 MYFORD ROAD
TUSTIN
CA
92780
1
0
0
0
0
Common Stock, $0.001 par value
2023-12-14
4
M
0
9612
A
55760
D
Common Stock, $0.001 par value
2023-12-15
4
P
0
23000
5.858
A
78760
D
Restricted Stock Units
2023-12-14
4
M
0
9612
0
D
Common Stock
9612
7014
D
Restricted Stock Units
2023-12-14
4
A
0
26756
0
A
Common Stock
26756
33770
D
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $5.825 to $5.90. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023.
Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date.
/s/ Stephen Hedberg, by Power of Attorney for Richard B. Hancock
2023-12-18